Abstract

BackgroundTo explore an expression profile in plasma exosomal miRNAs of mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE + HS) patients and investigate the associated clinical significance and putative pathways involved.MethodsPlasma exosomal miRNAs were measured in six mTLE + HS patients who were confirmed with pre-surgical stereo-electroencephalography and six without hippocampal sclerosis (mTLE−HS) using Illumina HiSeq 2500. Then six dysregulated miRNAs were chosen for validation in an independent sample of 18 mTLE + HS patients and 18 mTLE−HS controls using RT-qPCR. Receiver operating characteristic curve was conducted to evaluate the diagnostic value of miRNAs in HS. Bioinformatic analyses were conducted to reveal in which pathways these miRNAs were involved.ResultsWe revealed that a total of 42 exosomal miRNAs were differentially expressed in mTLE + HS. Among them, 25 were increased and 17 decreased. After validation, hsa-miR-129-5p, -214-3p, -219a-5p, and -34c-5p were confirmed as being upregulated, while hsa-miR-421 and -184 were significantly downregulated in mTLE + HS. Moreover, hsa-miR-184 had the best diagnostic value for discriminating mTLE + HS with 88.9% sensitivity and 83.3% specificity. These six miRNAs regulated several genes from neurotrophin-, hippo-, p53-, TGF- beta-, HIF- 1-, mTOR-related pathways.ConclusionSix miRNAs were dysregulated in mTLE + HS patients and targeted several genes. This result might facilitate pathological mechanistic studies of miRNAs in HS and represent potential diagnostic biomarkers. These provided the rationale for further confirmation studies in larger cohorts of prospective patients.

Highlights

  • MATERIALS AND METHODSMesial temporal lobe epilepsy with hippocampal sclerosis, which is the most common type of focal epilepsy, is clinically characterized by spontaneous recurrent seizures

  • We revealed that a total of 42 exosomal miRNAs were differentially expressed in mTLE + HS

  • Six miRNAs were dysregulated in mTLE + HS patients and targeted several genes

Read more

Summary

Introduction

Mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE + HS), which is the most common type of focal epilepsy, is clinically characterized by spontaneous recurrent seizures. Existing antiepileptic drugs (AEDs) are ineffective in approximately 30–35% of patients (Pitkanen et al, 2016). Epilepsy surgery is an invasive procedure with some risk of complications, including bleeding, infection, and stroke. In this context, identification of new biomarker for mTLE + HS may help accurately select these patients and, may help monitor HS progression (Zhou, 2019). To explore an expression profile in plasma exosomal miRNAs of mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE + HS) patients and investigate the associated clinical significance and putative pathways involved

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call